UCB (UCBJF) recently presented positive data on Cimzia (certolizumab pegol) from a late-stage trial (RAPID-PsA), conducted in patients suffering from psoriatic arthritis. The data was presented ...
via Investopedia.com Headlines http://www.investopedia.com/stock-analysis/Zacks/UCBPresentsPromisingCimziaData-AnalystBlog.aspx
8233 Old Courthouse Rd Ste 330 Vienna V.A. 22182
Matt Sileno
The Intuitive Group Inc
No comments:
Post a Comment